Metabolism of myo -Inositol by Legionella pneumophila Promotes Infection of Amoebae and Macrophages

Abstract

Legionella pneumophila is a natural parasite of environmental amoebae and the causative agent of a severe pneumonia termed Legionnaires' disease. The facultative intracellular pathogen employs a bipartite metabolism, where the amino acid serine serves as the major energy supply, while glycerol and glucose are mainly utilized for anabolic processes. The L. pneumophila genome harbors the cluster lpg1653 to lpg1649 putatively involved in the metabolism of the abundant carbohydrate myo-inositol (here termed inositol). To assess inositol metabolism by L. pneumophila, we constructed defined mutant strains lacking lpg1653 or lpg1652, which are predicted to encode the inositol transporter IolT or the inositol-2-dehydrogenase IolG, respectively. The mutant strains were not impaired for growth in complex or defined minimal media, and inositol did not promote extracellular growth. However, upon coinfection of Acanthamoeba castellanii, the mutants were outcompeted by the parental strain, indicating that the intracellular inositol metabolism confers a fitness advantage to the pathogen. Indeed, inositol added to L. pneumophila-infected amoebae or macrophages promoted intracellular growth of the parental strain, but not of the ⌬iolT or ⌬iolG mutant, and growth stimulation by inositol was restored by complementation of the mutant strains. The expression of the P iol promoter and bacterial uptake of inositol required the alternative sigma factor RpoS, a key virulence regulator of L. pneumophila. Finally, the parental strain and ⌬iolG mutant bacteria but not the ⌬iolT mutant strain accumulated [U-14 C 6 ]inositol, indicating that IolT indeed functions as an inositol transporter. Taken together, intracellular L. pneumophila metabolizes inositol through the iol gene products, thus promoting the growth and virulence of the pathogen. IMPORTANCEThe environmental bacterium Legionella pneumophila is the causative agent of a severe pneumonia termed Legionnaires' disease. The opportunistic pathogen replicates in protozoan and mammalian phagocytes in a unique vacuole. Amino acids are thought to represent the prime source of carbon and energy for L. pneumophila. However, genome, transcriptome, and proteome studies indicate that the pathogen not only utilizes amino acids as carbon sources but possesses broader metabolic capacities. In this study, we analyzed the metabolism of inositol by extra-and intracellularly growing L. pneumophila. By using genetic, biochemical, and cell biological approaches, we found that L. pneumophila accumulates and metabolizes inositol through the iol gene products, thus promoting the intracellular growth, virulence, and fitness of the pathogen. Our study significantly contributes to an understanding of the intracellular niche of a human pathogen. L egionella pneumophila is a Gram-negative ubiquitous environmental bacterium that survives in complex multispecies biofilms in natural or manmade water sources (1-3). Predominantly, however, Legionella spp. parasitize free-living protozoa and grow within these u...

Proteome remodelling by the stress sigma factor RpoS/σS in Salmonella: identification of small proteins and evidence for post-transcriptional regulation

“…It is noteworthy that myo-inositol catabolism confers a fitness advantage to Legionella pneumophila in macrophages and amoebae, and that σ S has a positive effect on expression of the iol operon and myo-inositol uptake 48 . It is possible that expression of the Salmonella prp , iol and fuc genes is activated in vivo by σ S and provides fitness advantages to the pathogen.…”

Effects ofMyo-inositol on Type 1 Retinopathy of Prematurity Among Preterm Infants <28 Weeks’ Gestational Age

“…In vitro data have shown that infection of macrophages by some intracellular bacteria is enhanced by their ability to use myo-inositol as an energy source. 25 An additional issue for this trial was its suspension when particulates (later identified as glass lamellae) were found in the third lot of drug, which was never used. Glass (27) Pulmonary hemorrhage 5/50 (10) 7/33 (21) Necrotizing enterocolitis 9/50 (18) 5/33 (15) Spontaneous gastrointestinal perforation 5/50 (10) 5/33 (15) Immaturity 4/50 (8) 5/33 (15) Bronchopulmonary dysplasia 6/50 (12) 2/33 (6) Other infection 6/50 (12) 0 Pulmonary hypoplasia 0 3/33 (9) Pneumonia 2/50 (4) 0 Congenital malformation 1/50 (2) 1/33 (3) Multiple organ failure 0 1/33 (3) Hepatic failure or cirrhosis 0 1/33 (3) Patent ductus arteriosus 0 1/33 (3) Any other cause of death 11/50 (22) 7/33 (21) a There may have been more than 1 primary or contributing cause of death.…”

High‐quality draft genome sequence of Gaiella occulta isolated from a 150 meter deep mineral water borehole and comparison with the genome sequences of other deep‐branching lineages of the phylum Actinobacteria

“…This gene was also not found in the genomes of other bacterial strains capable of myo-inositol catabolism such as Clostridium perfringens, Legionella pneumophila, and Enterobacter aerogenes. It is possible that the iolJ gene is replaced by a yet annotated aldolase gene (Berman & Magasanik, 1966;Kawsar, Ohtani, Okumura, Hayashi, & Shimizu, 2004;Manske, Schell, & Hilbi, 2016). impossible to obtain enough cell mass to perform enzymatic assays for RuBisCO activity.…”